TP53 and cancer: The inhibition of HSP90 stabilizes mutated nuclear p53 in cancer cells [38], and HSP90 inhibitors have been shown to induce apoptosis in cervical cancer cell lines in vitro, albeit with limited efficacy in xenograft models [39].